Abstract: The complex structures in cancer genomes are obtained through the revolution of high-throughput technology. The major challenge involves the interpretation of complex sceneries of genomic ...
(RTTNews) - Processa Pharmaceuticals, Inc. (PCSA) reported preliminary Phase 2 data showing that its lead oncology candidate, NGC-Cap, a combination of PCS6422 and capecitabine, significantly ...
Every minute, four Americans are told they have cancer and start a journey into one of the most complex diseases in medicine. Now, a new AI tool developed by Microsoft Research and covered today in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback